Bertrand L. Chenard - Concepedia

Author

Bertrand L. Chenard

Pfizer (United States)

Also Known As

Bertrand Chenard, Bertrand L Chenard, Bertrand L. Chenard

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Repligen (United States)Pfizer (United Kingdom)

About

Bertrand L. Chenard is an author at Pfizer (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	467
2	Engineering	8	8	250
3	Natural Sciences	8	8	205
4	Health Sciences	1	1	59
5	Allergy	1	1	26

Bertrand L. Chenard

Publications

Citations

H-Index

Page 1

	Year	Citations
Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice Stefan Just, Bertrand L. Chenard, Angelo Ceci, PLoS ONE	2018	135
CP-101,606, a potent neuroprotectant selective for forebrain neurons Frank S. Menniti, Bertrand L. Chenard, Mary Collins, European Journal of Pharmacology Forebrain NeuronsNeurotransmitterNeuropharmacologyNeurotransmissionNeurology	1997	111
.alpha.-Nitroarylation of ketones and esters: an exceptionally facile synthesis of indoles, 2-indolinones and arylacetic acids T. V. RajanBabu, Bertrand L. Chenard, Michael A. Petti The Journal of Organic Chemistry Arylacetic AcidstBiosynthesisEngineeringNatural Product SynthesisBiochemistry	1986	85
Transient receptor potential ion channels as targets for the discovery of pain therapeutics. James E. Krause, Bertrand L. Chenard, Daniel N. Cortright PubMed Acute PainPain MedicineTrpv1 AntagonistsImmunologyTransient Receptor Potential	2005	59
CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents Frank S. Menniti, Martin J. Pagnozzi, Paul Butler, Neuropharmacology MedicineNeuropharmacologyNeuroscienceMolecular NeurobiologyPharmacology	2000	56
Effect of CP101,606, a Novel NR2B Subunit Antagonist of the <i>N</i> -Methyl- <scp>d</scp> -Aspartate Receptor, on the Volume of Ischemic Brain Damage and Cytotoxic Brain Edema After Middle Cerebral Artery Occlusion in the Feline Brain Di Xiao, Ross Bullock, Joe C. Watson, Stroke	1997	54
C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells Daniel N. Cortright, Robin Meade, Stephen M. Waters, Current Eye Research	2009	51
Characterization of the Binding Site for a Novel Class of Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists Frank S. Menniti, Bertrand L. Chenard, Mary B. Collins, Molecular Pharmacology	2000	49
Quinazolin-4-one α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonists: Structure−Activity Relationship of the C-2 Side Chain Tether Bertrand L. Chenard, Willard M. Welch, James F. Blake, Journal of Medicinal Chemistry Combinatorial ChemistryReceptor AntagonistsMethylamino Tether GroupChemical BiologyPharmaceutical Chemistry	2001	45
Annelation reactions of quinone monoketals. Studies directed at an efficient synthesis of anthracyclinones Bertrand L. Chenard, Mark G. Dolson, Anthony D. Sercel, The Journal of Organic Chemistry Combinatorial ChemistryMolecular SciencesAnnelation ReactionsEngineeringHeterocyclic	1984	38

Page 1